Australian (ASX) Stock Market Forum

BLT - Benitec Biopharma

Jump to new
I'm surprised there hasn't been any commentry on this one given that it as gone up nearly 100% in just under a month:eek:. Maybe traders are now only looking at short trades?

Part of the report released to the market on Tuesday is as following:- Researchers at the University of Westminster in the United Kingdom (UK) have indicated “robust confidence” in Benitec’s ddRNAi-*‐based drug TT-*‐034 for hepatitis C based on their research data. In a Press Release dated 17 February, 2014 in the UK, they have detailed their pivotal role in developing a “groundbreaking method”....

If you are interested and would like to read the whole announcement then you can do so by clicking on this link:- http://stocknessmonster.com/news-item?S=BLT&E=ASX&N=782882

The company also received a speeding ticket yesterday:- http://stocknessmonster.com/news-item?S=BLT&E=ASX&N=783751

140221 - BLTs.gif​
 
Just keeps going up & up presently. The company released an announcement to the market today, here is part of it:- Benitec Biopharma Raises up to $31.5 million

Benitec Biopharma Limited (ASX:BLT), today announced it has entered into agreements for a Private Placement (the Placement) to raise up to approximately AUD$31.5 million from international institutional investors who include US based RA Capital Management, Perceptive Advisors, Special Situations Funds and Sabby Management as well as existing institutional and professional investors in Australia. The new international institutional investors comprise leading US.....

If you wish to read the rest of the announcement, then you can do so by clicking on the following link:- http://stocknessmonster.com/news-item?S=BLT&E=ASX&N=784060

140224 - BLTs.gif​
 
It's stocks like this that make one lose their hair prematurely, especially when one doesn't put their own money into it:(. I hope others here were bolder and did invest in it when I first posted on it around the 84/85c mark.

140225 - BLTs.gif​
 
piggybank said:
I'm surprised there hasn't been any commentry on this one given that it as gone up nearly 100% in just under a month:eek:. Maybe traders are now only looking at short trades?

Part of the report released to the market on Tuesday is as following:- Researchers at the University of Westminster in the United Kingdom (UK) have indicated “robust confidence” in Benitec’s ddRNAi-*‐based drug TT-*‐034 for hepatitis C based on their research data. In a Press Release dated 17 February, 2014 in the UK, they have detailed their pivotal role in developing a “groundbreaking method”....

If you are interested and would like to read the whole announcement then you can do so by clicking on this link:- http://stocknessmonster.com/news-item?S=BLT&E=ASX&N=782882

The company also received a speeding ticket yesterday:- http://stocknessmonster.com/news-item?S=BLT&E=ASX&N=783751

Click to expand...
Shrna detected in patient
 
Benitec Biopharma out of the gates quickly this morning after announcing that the U.S. Food & Drug Administration (FDA) has granted Orphan Drug Designation to BB-301 for the treatment of oculopharyngeal muscular dystrophy (OPMD).

Up 4c to 27.5c since the open.

BLT bottomed out at around 9c in June 2016 but appears to be slowly staging a comeback.

screenshot-shareinvesting.anz.com-2018-01-15-09-28-48.png
 
Benitec having a cap-raise, on a 1 (new share) for 2 (existing) basis. 17c.
I don't pretend to understand the biology - ddRNAi: if it works it would be a ground breaker.
BLT has been in the early stages of product research and development for a looong time.
I have held in the past - but not during the heady days of 2014, when my worthless BLTO oppies suddenly became worth something, to my amazement.
So for me it's a case of caution: can a souffle rise twice?

Watching with interest.
One for the brave, says this chicken.

regards,
P
 
Big news for Benitec Biopharma today and equally big share price move north.

This morning the company announced that it has licensed to Axovant Sciences the exclusive global rights for BB-301 (now named AXO-AAV-OPMD) intended for the treatment of oculopharyngeal muscular dystrophy (OPMD), and has also entered into a fully funded research collaboration for the development of five additional gene therapy products in neurological disorders.

Under the terms of the agreement, Benitec will receive an upfront cash payment of US $10 million and additional cash payments totaling US$17.5 million upon completion of four specific near-term manufacturing, regulatory and clinical milestones. Axovant has been granted worldwide rights to AXO-AAV-OPMD and will assume all future development costs. The total potential value of all of the development, regulatory and commercial milestones achievable by Benitec, of which there are eight milestones including the four near-term milestones, is US$187.5 million.

Benitec will retain 30% of the net profits on the worldwide sales of AXO-AAV-OPMD.

BLT currently up 72.41% to 25c this morning with an intraday high of 29.5c. Volume of 4.3 million shares.

big.chart-BLT.gif
 
Top Rising stock today closing at $0.305 cents … up 110% … 16+ million shares … Big day if you were a holder:(:D
 
As is often the case … A big rise is followed by a big fall ….. On the watchlist for now


BLT 10July2018.jpg
 
On April 16th, 2020, Benitec Biopharma Limited (BLT) was removed from the ASX's Official List in accordance with Listing Rule 17.11, following implementation of the scheme of arrangement between BLT and its shareholders in connection with the acquisition of all the issued capital in BLT by Benitec Biopharma Inc.
 
So it's bye-bye Benitec. Long to be remembered by yours truly as the one that got away, especially BLTO oppies.
I thought about it, and decided, nah: no way will these oppies conceivably be in the money before expiration date (a couple months ahead).
They went from utterly loveless $0.001, to $2.00. Early 2014, IIRC.
Live and learn.
 
Top